NewYorkBIO

Brian Dershowitz and Christopher Kiesel have a packed day tomorrow attending events across New York's life science ecosystem - be sure to connect with them in-person at the events!

Life Science professionals, today is your last chance to complete our survey! ?? ICYMI: NewYorkBIO and New York City Economic Development Corporation are partnering to create a resource hub of life science information throughout New York State. To achieve this, we have asked individuals across the life science ecosystem to complete a short survey?to help us better understand needs, challenges, and outlook. Complete the survey today to ensure your voice is reflected in this forthcoming critical industry tool! Don’t wait, complete the short survey now: https://lnkd.in/eXRhEZpW

There is still time to complete our survey to inform NewYorkBIO and New York City Economic Development Corporation's forthcoming resource hub of life science information for members of the industry throughout New York State. Help us better understand industry needs, challenges, and outlook by completing the survey before March 17!

I hope you will join me for this important NewYorkBIO event. Please share with your patient advocate network as well. All are welcome!

Registration is live for NewYorkBIO’s 2025 Patient Engagement Summit! Scheduled for Thursday, April 10th, from 12:30 – 6:30pm at the Genome Center in Manhattan, this hybrid event is designed to bring together patient advocacy groups and leaders from the biotech and life sciences sectors to spotlight the vital role of patient participation in drug discovery.? ?? Join us to foster meaningful connections and advance the conversation on patient engagement! Register today: https://bit.ly/3FmQIeQ??

Calling all who work in the #lifesciences space! ?? NewYorkBIO and New York City Economic Development Corporation are partnering to create a resource hub of life science information throughout New York State. To achieve this, we are asking individuals across the life science ecosystem to complete a short survey?to help us better understand your needs, challenges, and outlook. Survey responses should be submitted by March 17 to ensure all voices are reflected in this critical industry tool! Complete the short survey now:

Join NewYorkBIO at our first Mini-Pitch Day of 2025 on March 31 at Crowell & Moring: Two Manhattan West, 375 9th Ave, New York, NY! ? We look forward to hosting early-stage life science and biotech companies with the unique opportunity to pitch their company and receive valuable feedback from life science leaders. ? With a networking reception to follow, you do not want to miss this. Register today: https://bit.ly/4bskBq7

NewYorkBIO is thrilled to welcome Brian Dershowitz to our team as the new Vice President of Strategic Partnerships and Initiatives! Brian will be focused on expanding NewYorkBIO’s influence and impact through strategic partnerships and programs aligned with the organization’s mission and goals. Brian will work to unite key industry voices and companies of all sizes with resources to support transformative change on behalf of NewYorkBIO's thriving life science ecosystem. Be sure to connect with Brian at one of our upcoming events!

It was a packed house at last week’s Networking Reception hosted by WilmerHale. Special thank you to Andrew Kimball, President & CEO of New York City Economic Development Corporation, and Glenn Pollner, Partner at WilmerHale, for such an engaging fireside chat that offered the audience valuable insights on the future of the life science industry and the forward trajectory of New York City. In case you missed this event, be sure to follow NewYorkBIO for more updates on upcoming events and opportunities to engage.?

NewYorkBIO joins the National Organization for Rare Disorders in recognizing #RareDiseaseDay, in honor of the more than 30 million Americans living with a rare disease?and the more than 1.8 million New Yorkers living with a rare disease. Today and every day, NewYorkBIO is proud to play a role in propelling innovation of treatments and cures for our rare disease patients across the globe. As the leading advocate for New York’s life science community, we are also proud to support the effort to establish a New York Rare Disease Advisory Council (RDAC) that will give our rare disease community a stronger voice in state government. Together, we can continue driving innovation and supporting the bioscience companies working to develop future cutting-edge treatments, cures, and technologies to bring new hope to rare disease patients and their families.